Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201620172018201920202021
Sales177 526184 765194 579252 468257 902267 648
EBITDA13 05312 65312 97317 42018 18619 588
Operating profit (EBIT)11 3739 98710 25514 37515 00115 587
Pre-Tax Profit (EBT)------
Net income5 3176 622-5946 5457 4047 886
P/E ratio16,111,3-11510,59,337,89
EPS ( $ )4,906,44-0,575,025,666,69
Dividend per Share ( $ )1,702,002,001,991,992,04
Yield2,15%2,76%3,05%3,76%3,77%3,87%
Reference price ( $ )78.9172.565.5252.7952.7952.79
Announcement Date02/09/2017
11:55am
02/08/2018
11:55am
02/20/2019
11:55am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201620172018201920202021
Debt24 07325 19566 84864 15757 98851 568
Finance------
Operating income (EBITDA)13 05312 65312 97317 42018 18619 588
Leverage
(Debt/EBITDA)
1,84x1,99x5,15x3,68x3,19x2,63x
Capital Expenditure2 2241 9182 0372 5242 6142 755
Book Value Per Share (BVPS)34,7 $37,1 $45,0 $53,5 $58,0 $63,5 $
Cash Flow per Share9,33 $7,82 $8,47 $7,98 $8,81 $9,51 $
Announcement Date02/09/2017
11:55am
02/08/2018
11:55am
02/20/2019
11:55am
---
Balance Sheet Analysis
Assessed data source :
© 2019 Thomson Reuters
Financial Ratios

Size 2019e 2020e
Capitalization 68 579 M$ -
Entreprise Value (EV) 132 737 M$ 126 567 M$
Valuation 2019e 2020e
P/E ratio (Price / EPS) 10,5x 9,33x
Capitalization / Revenue 0,27x 0,27x
EV / Revenue 0,53x 0,49x
EV / EBITDA 7,62x 6,96x
Yield (DPS / Price) 3,76% 3,77%
Price to book (Price / BVPS) 0,99x 0,91x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 5,69% 5,82%
operating Leverage (Delta EBIT / Delta Sales) 1,35x 2,02x
Net Margin (Net Profit / Revenue) 2,59% 2,87%
ROA (Net Profit / Asset) 4,67% 4,82%
ROE (Net Profit / Equities) 13,5% 12,8%
Rate of Dividend 39,6% 35,1%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   1,00% 1,01%
Cash Flow / Sales 4,11% 4,44%
Capital Intensity (Assets / Sales) 0,56x 0,60x
Financial Leverage (Net Debt / EBITDA) 3,68x 3,19x
EPS & Dividend